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Introduction

Historically, female athletes only compete against other female athletes,
males against males. Over the last few decades, this concept and definition of
female and male in athletics has been a hotly-discussed topic. This is especially so
at the highest level of international track and field, where the quest to eliminate
cheaters who consume illicit performance enhancing drugs is a top priority. As
technology has improved, there is a greater ability to determine what substances
give an unfair competitive advantage and detect when those banned substances are
present in an athlete. The understanding of human biology has also developed
exceedingly. While this growth in understanding has been immensely beneficial to
general human existence, these same development seem to be taking a toll on
female athletes who are intersex or hyperandrogenic.
II.

Historical & legal overview of the problem

Intersex is a broad term “used for a variety of conditions in which a person
is born with a reproductive or sexual anatomy that doesn’t seem to fit the typical
definitions of female or
male.”1 There are various ways intersex can present itself. For example, “a person
might be born appearing to be female on the outside, but having mostly maletypical anatomy on the inside.”2 In another instance, a “person may be born with
mosaic genetics, so that some of her cells have XX chromosomes and some of them
have XY.”3 Intersex characteristics are not always present at birth. Many times
people do not discover they are intersex until puberty or upon discovering
infertility.4 Often people never discover it during life but it is discovered during an
autopsy.5
Hyperandrogenism is a medical condition causing a person to produce high
levels of hormones.6 While there are various forms of hyperandrogenism, the
International Association of Athletics Federations (IAAF) regulates the form of
hyperandrogenism in intersex female athletes where they produce testosterone at
much higher levels than the female average.7 The IAAF has taken the position that
hyperandrogenic female athletes should not be allowed to compete until they take
action to suppress naturally occurring high levels of testosterone.8

1

What is intersex?, Intersex Society of North America, 2008.
Id.
3
Id.
4
Id.
5
Id.
6
Hyperandrogenism explained and what it means for athletics, USA Today, Aug. 2, 2016.
7
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8
Sean Ingle, Sebastian Coe: IAAF right to seek court ruling over hyperandrogenism issue, The Guardian, Aug. 12,
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Testing for the sex of an athlete, has been around in track and field for
decades. In fact, the use of anabolic doping agents was first recorded at the 1952
Olympic Games, with wide belief that the first use was German athletes at the 1936
Olympic Games.9 First, it was a basic physical examination; later it was a
chromosome test. In the 1980s, however, the IAAF considered testosterone levels
when determining who was “woman enough” to participate in competitions after
Spanish hurdler Maria Martinez-Patino was unfairly thrown off Spain’s Olympic
team based on a chromosome test.10 In 2011, the IAAF began “a three-stage
medical examination process if it suspected a female athlete had
hyperandrogenism.”11 Between the 1980s and 2011, the IAAF handled the issue of
intersex female athletes and hyperandrogenism on a case-by-base basis.12 This
remains. Because the IAAF believes testosterone to be the most significant trait
enhancing athletic performance, the IAAF feels hyperandrogenic women have an
unfair performance advantage over other female athletes. To the IAAF, this belief
results in requiring these hyperandrogenic female athletes to actively lower their
testosterone levels. The IAAF has taken this stance to ensure fair, level competition,
understanding that in these circumstances, nobody is cheating and this is purely a
biological issue.13
III.

Overview of laws in place

Who is the IAAF
The IAAF is the governing body of world competition, making the rules
and decisions regarding equipment and doping in international track and field
competition.14 The organization is a signatory of the World Anti-Doping Code,
rules that have been adopted by the IAAF Council.15 The Athletics Integrity Unit
enforces these rules on international-level athletes and athletic personnel in regards
to “education, testing, investigations, results management, hearings, sanctions, and
appeals.”16 In implementing these rules, the Athletics Integrity Unit board appoints
an Independent Anti-Doping Review Panel approves, monitors, and provides
suggestions regarding the anti-doping program, advising the Athletics Integrity
Unit on anti-doping.17 The IAAF and the International Olympic Committee (IOC)
have spent over half a century aggressively trying to determine who is a woman for
the purposes of international competition.

9

M.L. Healy et al., Endocrine profiles in 693 elite athletes in the post competition setting, 81 Clinical
Endocrinology, 294, 298 (2014).
10
Hyperandrogenism explained and what it means for athletics, USA Today, Aug. 2, 2016.
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Id.
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Hyperandrogenism explained and what it means for athletics, USA Today, Aug. 2, 2016.
13
Id.
14
International Association of Athletics Federations, About the IAAF, https://www.iaaf.org/about-iaaf.
15
Sean Ingle, Sebastian Coe: IAAF right to seek court ruling over hyperandrogenism issue, The Guardian, Aug. 12,
2017.
16
Id.
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Id.
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What is “doping”
The definition of doping is multidimensional. It is the “presence of a
prohibited substance or its metabolites or markers in an athlete’s sample.”18 It is the
“use or attempted use by an athlete of a prohibited substance or a prohibited
method.”19 Doping is also “evading, refusing or failing to submit to sample
collection”, “tampering or attempted tampering with any part of doping control”,
“possession of a prohibited substance or a prohibited method”, “trafficking or
attempted trafficking in any prohibited substance or prohibited method”,
complicity, prohibited association, and the administration or attempted
administration of a prohibited substance or method to any athlete in or out of
competition.20 Lastly, doping is “any combination of three missed tests and/or filing
failures.” 21 In other words, an athlete is “doping” if she is born with what is
considered a “banned substance” such as a certain level of testosterone.
Banned Substances
The World Anti-Doping Agency (WADA) establishes the list of prohibited
substances. A list is established every year and is valid from January 1 to December
31 of that year. Some substances are prohibited both in and out of competition while
other substances are only banned in competition. There are also banned substances
specific to sport. These banned “substances” include both substances and methods.
The following substances are banned in and out of competition: anabolic
agents; peptide hormones, growth factors, and related substances and mimetics;
beta-2 agonists; hormone and metabolic modulators; diuretics and masking agents;
and non-approved substances.22 The following are methods banned in and out of
competition: manipulation of blood and blood components; chemical and physical
manipulation; and gene doping.23
An example of an anabolic agent is an anabolic androgenic steroid.
Testosterone is an endogenous anabolic androgenic steroid. Testosterone is a
banned substance because of its numerous “potential” performance-enhancing
effects. These include “boosting the oxygen-carrying capacity of the blood,
building lean muscle mass and increasing mental drive and aggressiveness.”24

18

Anti-Doping Rule Violation 2.1.1.
Anti-Doping Rule Violation 2.2.
20
Anti-Doping Rule Violation 2.3, 2.5-2.10.
21
Anti-Doping Rule Violation 2.4.
22
World Anti-Doping Agency, What is prohibited, 2017, https://www.wada-ama.org/en/prohibited-list/
prohibited-at-all-times.
23
Id.
24
Martha Kelner and James Rudd, Caster Semenya could be forced to undertake hormone therapy for future
Olympics, The Guardian, July 3, 2017.
19
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Some studies indicate female athletes might experience “improved visuospatial
abilities.”25
Permitted Substances & Treatments, Exceptions
With respect to testosterone, a female athlete is eligible to compete in the
women’s competitions if she has blood testosterone levels below 10 nmol/L, which
is the lower limit of testosterone for men.26 Anything above 10 nmol/L is
considered an advantage that is subject to the anti-doping regulations, even if that
testosterone level is naturally occurring.
Testing
Under the Anti-Doping Rules, testing and investigating shall only occur for
anti-doping purposes.27 Testing athletes provides evidence of compliance or noncompliance with the Anti-Doping regulations. When there are findings adverse to
the Anti-Doping regulations, investigations will occur to gather intelligence and
evidence to determine whether a violation actually occurred. Investigations are not
limited to adverse findings. Any athlete, who has not retired, may be subject to
testing. The Integrity Unit plus any anti-doping organization with testing
authoritative powers, can require an athlete to provide a sample at anytime and
anyplace.28 This includes athletes serving a suspension or period of ineligibility.29
Testing for and diagnosis of hyperandrogenism in the elite international
athletic world “considers only high testosterone and tissue sensitivity.”30 The IAAF
and IOC use serum testosterone as the sole biological variable to regulate women’s
participants’ eligibility.31 Female athletes with testosterone levels about 10 nmol/L
are required to either (1) undergo medical intervention to lower the levels or (2)
risk being banned from women’s events.32 These testosterone levels and
hyperandrogenism under the IAAF are determined through “systematic hormonal
screening” to fulfill the “athlete biological passport [ABP].”33 The ABP monitors
“selected biological variables over time that indirectly reveal the effects of doping
rather than attempting to detect the doping substance or method itself.”34
25

Id.
Peter Sonsken et al., Medical and Ethical Concerns Regarding Women with Hyperandrogenism and Elite Sport,
The Journal of Clinical Endocrinology and Metabolism, 825 (Mar. 1, 2015).
27
IAAF Anti-Doping Rules 5.1.
28
IAAF Anti-Doping Rules 5.2.1.
29
Id.
30
Rebecca M. Jordan Young, Peter H. Sonsken, and Katrina Karkazis, Sex, health, and athletes, BMJ, at 1, Apr. 28,
2014.
31
Peter Sonsken et al., Medical and Ethical Concerns Regarding Women with Hyperandrogenism and Elite Sport,
The Journal of Clinical Endocrinology and Metabolism, 825, 825 (Mar. 1, 2015).
32
Id.
33
Rebecca M. Jordan Young at 2.
34
World Anti-Doping Agency, Athlete Biological Passport, 2017, https://www.wada-ama.org/en/athlete26
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Under the IAAF, full testing processes for testosterone begin with a clinical
examination and endocrine assessment that determines whether or not there are
grounds for classifying a female athlete as hyperandrogenic.35 If such grounds are
found, at least a full physical and gynecological examination incur, with endocrine
assessments of blood and urine, medical history including family medical history,
and psychological assessments. 36 This includes “measuring and palpating the
clitoris, vagina and vulva, as well as evaluating breast size and pubic hair scored on
an illustrated five-grade scale.”37
Organizations like the IAAF “integrate the Athlete Biological Passport into
the larger framework of robust anti-doping program in order to: [i]dentify and target
athletes for specific analytical testing by intelligent and timely interpretation of
Passport data; and [p]ursue possible anti-doping rule violations based on atypical
passport [. . .] .“38 In other words, while the ABP requires the IAAF to regulate
doping, the IAAF chooses to implement the highly questionable, unideal
regulations on natural testosterone.
Proof of doping
The IAAF, or other Anti-Doping organization with power, has the burden
of establishing that an anti-doping violation has occurred.39 The IAAF or other
organization, has to establish “the commission of the alleged Anti-Doping Rule
Violation to the comfortable satisfaction of the hearing panel, bearing in mind the
seriousness of the allegation that is made.”40 This standard of proof is not to the
level of beyond a reasonable doubt and is somewhere between preponderance of
the evidence and clear and convincing evidence. Facts proving an anti-doping
violation “may be established by any means”, which includes the following:
admissions; analytical methods; compliance with an official international standard;
WADA-accredited and WADA-approved laboratories; those facts established by
“a court or professional disciplinary tribunal of competent jurisdiction that is not
the subject of a pending appeal”; and inferences drawn by a hearing panel in a
hearing based on the accused’s refusal or failure to respond to questions from an
investigation or requests prior to a hearing.41

biological-passport.
35
Jordan Young at 2.
36
Rebecca M. Jordan Young, Peter H. Sonsken, and Katrina Karkazis, Sex, health, and athletes, BMJ, at 2, Apr. 28,
2014.
37
Ruth Padawer, The Humiliating Practice of Sex-Testing Female Athletes, The New York Times, Jun. 28, 2016.
38
World Anti-Doping Agency, Athlete Biological Passport, 2017, https://www.wada-ama.org/en/athletebiological-passport.
39
IAAF Anti-Doping Rules 3.1.
40
Id.
41
IAAF Anti-Doping Rules 3.2.
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On rebuttal, the athlete, or whoever is alleged to have committed the
violation, has to refute the established presumption or establish specific facts or
circumstances by a preponderance of the evidence, or “a balance of probability.”42
Managing Results & Hearing
Results management & investigation
Hearings and managing athlete testing results are governed by the
procedural rules of the national federation or Anti-Doping organization that
initiated or directed the athlete testing and sample collection. 43 However, the
Integrity Unit, under the Anti-Doping Rules, has responsibility over results
management for investigations conducted by the Integrity Unit; possible violations
that arise where there has been testing conducted under the Anti-Doping Rules;
violations that arise where no testing has occurred; a National Anti-Doping
organization initiated the sample collection; and for a filing failure or missed test.
The Integrity Unit also oversees adverse ABP findings.
After the results management or investigation process by the Integrity Unit,
National Federation, or National Anti-Doping organization, if an Anti-Doping
Rules violation is asserted, the athlete or the person who committed the violation
will be notified of a violation and referred to a hearing.44
Hearing
The Disciplinary Tribunal is the IAAF established “court” with jurisdiction
over Anti-Doping Rules violations asserted by the Integrity Unit, National
Federation, or other National Anti-Doping organization.45 The Disciplinary
Tribunal has the following powers:
“to rule on its own jurisdiction; to appoint an independent expert to assist or advise
it on specific issues [. . .]; to expedite or to adjourn, postpone or suspend its
proceedings, upon such terms as it will determine, where fairness so requires; to
extend or abbreviate any time limit specified in any rules or by the Disciplinary
Tribunal itself; to order any party to make any property, document or other thing in
its possession or under its control available for inspection; to allow one or more
third parties to intervene or be joined in the proceedings, to make all appropriate
procedural directions in relation to such intervention or joinder, and thereafter to
make a single final decision or separate decisions in respect of all parties; to order
that certain preliminary and/or potentially dispositive questions [. . .] be heard and
determined in advance of any other issues in the matter; to award interim relief or
other conservatory measures on a provisional basis and subject to final
determination; to make any other procedural direction or take any other procedural
42

Id.
IAAF Anti-Doping Rules 7.1.
44
IAAF Anti-Doping Rule 8.1.
45
Id.
43

7

7:2

2019

Santa Clara Journal of International Law

steps which the Disciplinary Tribunal considers to be appropriate in pursuit of the
efficient and proportionate management of any proceeding or matter pending
before it; and to impose costs orders.”46
Hearings before the Disciplinary Tribunal begin with the head of the
Integrity Unit sending the “Notice of Charge” (written notice) to both the athlete or
person charged with the violation and the Disciplinary Tribunal chairperson.47 This
notice outlines the violations that have taken place, the Anti-Doping rule that has
been breached, a summary of the facts that are the basis for the allegation, the
applicable consequences, matters related to provision suspension, and the fact that
the athlete is entitled to respond to the notice.48
The person charged with the violation may respond in a number of ways:
admit to the charge and acquiesce to the consequences; admit to the charge but
dispute or attempt to mitigate the consequences; or deny the violation and have the
Disciplinary Tribunal decide, at the hearing, the charge, if it is upheld, and any
consequences.49
Upon receiving the notice of charge, the chairperson appoints one or three
members of the entire Disciplinary Tribunal to hear the case and decide the
violations alleged in the notice. Appointees cannot be involved if they have any
personal connection or interest to anyone involved; had any prior involvement with
any matter or facts giving rise to the proceedings; is the same nationality as the
party charged; or if impartiality or independence would be questioned as
determined by the chairperson.50
Both the Integrity Unit and the charged person have the right to be present
and heard at the hearing as well as be represented by legal counsel. 51 The charged
person may also submit a writing for the Disciplinary Tribunal panel to consider in
its deliberations.52 The hearings are conducted confidentially.53 After all
submissions, the Disciplinary Tribunal panel deliberates whether a violation has
occurred and what the consequence should be. The panel issues their decision, in
writing, within 14 days of the conclusion of the hearing, and sends the decision to
the parties, WADA, and whoever else has a right to appeal the decision. This
written decision contains and explains the findings, whether a violation has
occurred, the consequences, why the maximum consequence has not occurred, the

46

IAAF Anti-Doping Rule 8.6.1.
IAAF Anti-Doping Rule 8.6.1.
48
IAAF Anti-Doping Rule 8.4.2.
49
IAAF Anti-Doping Rule 8.4.3.
50
IAAF Anti-Doping Rule 8.5.2.
51
IAAF Anti-Doping Rule 8.8.2.
52
IAAF Anti-Doping Rule 8.8.3.
53
IAAF Anti-Doping Rule 8.8.1.
47
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date the consequence begins, the reasons of all the aforementioned, and the rights
surrounding appeal.54
Consequences
Anti-Doping violations have a number of consequences. Where there is an
Anti-Doping violation found from an in-competition test, the athlete is
automatically disqualified and forfeits medals, titles, awards, points, and prize and
appearance money.55 Results from other events the athlete has competed in may
also be disqualified.56 Consequences can vary greatly depending on whether it is
the athlete’s first offense and the degree of fault the offender has in the offense.
Where an athlete has committed an Anti-Doping violation, and it is the
athlete’s first Anti-Doping offense, the athlete shall be ineligible for four years
where the violation either did not involve a specified substance or does involve a
specified substance but the violation was unintentional.57 The period of ineligibility
is two years where the athlete, who failed to submit a sample, can show that the
violation was unintentional. For a first offense, the two year period of ineligibility
can be reduced to one year if the degree of fault is lower. 58 Where the athlete or
person who committed the violation can prove that he or she was simply negligent
or bears no fault at all, than the period of ineligibility is eliminated.59
The period of ineligibility may be eliminated, reduced, or suspended for
reasons that are not fault-related. One reason is substantially assisting the Integrity
Unit in discovering or establishing Anti-Doping Rule violations.60 Another reason
is where an athlete or other violator voluntarily admits to committing a violation
before other evidence has been established.61
Where the violation is the athlete or offender’s second offense, the period
of ineligibility is one of the following, whatever is greater: “six months; one-half
of the period of ineligibility imposed for the first anti-doping offense without taking
into account any reduction [. . .]; or twice the period of ineligibility that would be
applicable to the second Anti-Doping Rule violation if it were a first Anti-Doping
Rule violation, without taking into account any reduction [. . .].”62 Where a prior
violation has occurred within ten years of the recent violation, that prior violation
shall be taken into account to calculate the period of ineligibility. 63 When multiple

54

IAAF Anti-Doping Rule 8.9.2.
IAAF Anti-Doping Rule 9.1.
56
IAAF Anti-Doping Rule 10.1.
57
IAAF Anti-Doping Rule 10.2.1.
58
IAAF Anti-Doping Rule 10.3.2.
59
IAAF Anti-Doping Rule 10.4.
60
IAAF Anti-Doping Rule 10.6.1.
61
IAAF Anti-Doping Rule 10.6.2.
62
IAAF Anti-Doping Rule 10.7.1.
63
IAAF Anti-Doping Rule 10.7.5.
55

9

7:2

2019

Santa Clara Journal of International Law

violations have taken place at once, the ineligibility periods for each offense shall
run sequentially.64
Appealing
Athletes and others found to have committed an Anti-Doping Rules
violation may appeal the decision. For international-level athletes or athlete support
persons, or those involving international competitions, a decision can be appealed
exclusively to the Court of Arbitration for Sport (CAS).65 Disciplinary Tribunal
decisions may also be appealed exclusively to CAS.66 All other decisions “may be
appealed to an independent and impartial body in accordance with rules established
by the National Federation or National Anti-Doping Organisation.”67 WADA can
appeal a decision that was not rendered in a timely manner.68
Appealing to CAS must occur within 30 days from receipt of the decision.
Appeals must be filed with the CAS and IAAF on the same day69. Respondent has
30 days to file an answer with the CAS after receiving the appeal brief.70 Taking on
an appeal is up for the Anti-Doping Review Panel to decide. The CAS Code of
Sports-related Arbitration applies. Cross appeals and subsequent appeals are
permitted. Where the IAAF is involved, the CAS panel is bound by IAAF
constitution, rules, and regulations.71 The CAS’ decision is final and binding on all
parties and there is no right of appeal from the decision. 72
Luckily, the court of arbitration for sport has temporarily suspended the
IAAF’s disciplinary practices in regard to restricting permitted levels of
testosterone among female competitors. Nonetheless, the IAAF continues to this
day to stand by and argue for these practices, giving this paper relevance.
IV.

Argument & Analysis

The IAAF discriminates against female athletes with atypical sex
development. One highly publicized example of this, that will be discussed further
below, is the case of Dutee Chand. The IAAF uses advanced technology to
inequitably punish female athletes born intersex. These uses are intrusive, violative,
and often quite embarrassing to the female athletes, resulting in arbitrary
conclusions and decisions. Rather, the IAAF should and can use modern-day
technology to create and implement rules regarding testosterone doping in a more
just way. They have all the right tools, boards, and actors in place to make the right
64

IAAF Anti-Doping Rule 10.7.6.
IAAF Anti-Doping Rule 13.2.2.
66
IAAF Anti-Doping Rule 13.2.3.
67
IAAF Anti-Doping Rule 13.2.3.
68
IAAF Anti-Doping Rule 13.3.
69
IAAF Anti-Doping Rule 13.7.1.
70
Id.
71
IAAF Anti-Doping Rule 13.9.4.
72
IAAF Anti-Doping Rule 13.9.6.
65
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decisions, they just fail to fully utilize all the resources available to their fullest
capacity.
The IAAF and IOC concern for testosterone doping are understandable.
Fairness is allegedly one of the most important principles to the IAAF and IOC,
and testosterone is the “most widely abused performance-enhancing drug.”73 64 of
116 female athletes serving doping bans as of December 2016 tested positive for
androgens, or testosterone.74 The advantages from heightened testosterone levels
are, to the IAAF and their medical and science personnel, potentially quite
significant. At times the IAAF has been successful and just in monitoring doping
in female athletes.
For instance, the IAAF successfully found and penalized Russian sprinters
who had engaged in doping. Russia had state-sanctioned androgenic doping, and
Russian 800-meter 2012 London Olympic gold medalist Mariya Savinova was
stripped of her medal.75 She received a four-year ban and nullification of her July
2010 to August 2013 race results by the CAS for doping during that time period.
Savinova’s biological passport plus her videotaped admission of taking
oxandrolone, an anabolic steroid, were the CAS’ clear evidence of Savinova’s
doping.76 In the video, Savinova described how her coach, her husband, and others
had tested for and designed a sophisticated system for the oxandrolone to be in and
out of her body in 20 days.77 At least nineteen other Russian athletes have been
stripped of their 2008 or 2012 Olympics medals.78 As a result of this widespread,
systemic doping, the entire Russian track and field team was barred from competing
in the 2016 Olympic games in Rio.79 Consequently, Russia was also barred from
competing in the 2017 World Championships in London.80 This crackdown on
Russian female track doping is unrelated to naturally occurring high levels of
testosterone, and the action taken against Russia - the bans - is an understandable
punishment that furthers the interests of fairness.
While the IAAF may have the proper processes in place to make the best
decisions regarding doping with people actively taking banned substances and
methods, there are still many ways in which the IAAF is in the wrong. The IAAF’s
regulations of testosterone levels and hyperandrogenism in female athletes are

73

Martha Kelner and James Rudd, Caster Semenya could be forced to undertake hormone therapy for future
Olympics, The Guardian, July 3, 2017.
74
Martha Kelner and James Rudd, Caster Semenya could be forced to undertake hormone therapy for future
Olympics, The Guardian, July 3, 2017.
75
Colleen Curry, The face of Russia’s doping scandal: Mariya Savinova, The Guardian, Nov. 10, 2015.
76
Marissa Payne, Russian runner who admitted on video to doping is stripped of Olympic gold, The Washington
Post, Feb. 10, 2017.
77
Id.
78
Marissa Payne, Russian runner who admitted on video to doping is stripped of Olympic gold, The Washington
Post, Feb. 10, 2017.
79
Id.
80
Id.
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discriminatory, in opposition to the Olympic charter, unethical, and wholly without
scientific backing.
Discriminatory
The IAAF regulations on testosterone and who is woman enough to
participate are discriminatory against women and consequently discriminatory
against particular athletes because of their success. Men are not regulated nearly as
vigorously as women. These regulations on hyperandrogenism in women came to
fruition as a response to the success of Caster Semenya and are executed upon
suspicion that follows successful women track athletes such as Dutee Chand.
Following a discussion of the differences in IAAF treatment of men, the stories of
Semenya and Chand will be discussed further below.
Male athletes do not undergo even remotely similar invasive, dehumanizing
testing procedures as female athletes. There are no regulations of naturally
occurring advantages in male athletes. There never have been. In fact, these
naturally occurring higher levels of testosterone in male athletes are praised.
Furthermore, the regulation of the “presence of a prohibited substance or its
metabolites or markers in an athlete’s sample” such as naturally occurring high
levels of testosterone is discriminatorily practiced. Male athletes are not kept under
as watchful an eye as female athletes in regards to testosterone levels. Additionally,
female athletes are penalized for success, with the IAAF harshly coming down on
female athletes whose success is questioned as being the result of high testosterone.
The same cannot be said for the treatment and penalization of male athletes for
testosterone.
Caster Semenya
Caster Semenya is a South African middle distance runner and 2016
Olympic gold medalist. After the 2009 Berlin world championships, in which
Semenya, took 1st in the 800m, the IAAF received criticism for not properly
investigating her.81 The public questioned Semenya’s success as being a result of
high levels of testosterone, and in response the IAAF subjected Semenya to
“unwarranted and invasive scrutiny of the most intimate and private details” of
Semenya’s being. Semenya won the 2009 World Championships by a full two
seconds. Afterward, people insultingly called her a man. She was punished for
“being too fast and supposedly too masculine.”82 This was the catalyst for the
current policies the IAAF enacted in 2011.
If the IAAF has their way, Semenya, and other female athletes in the future,
could be forced to undertake hormone therapy for future Olympics and international

81

International Association of Athletics Federations, Semenya Rockets to the Top of the World, Aug. 26, 2009,
https://www.iaaf.org/competitions/iaaf-world-championships/news/semenyas-Rocketsto-the-top-of-the-world.
82
Jere Longman, Understanding the Controversy Over Caster Semenya, The New York Times, Aug. 18, 2016.
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competition.83 Male athletes do not face such threats of force. Male athletes are not
faced with invasive procedures and being thoroughly embarrassed the way
Semenya and other female athletes are made to feel. This treatment of Semenya
stemmed from negative, weak people upset with her success, something else that
does not happen to male athletes.
Dutee Chand
Dutee Chand is a record-breaking Indian sprinter. Her story and battle
against the IAAF, documented by The New York Times, started in June 2014, when
Chand was called in by the director of the Athletics Federation of India - the Indian
affiliate of the IAAF - to meet in Delhi.84 Upon arriving in Delhi, Chand was sent
to a clinic to meet with a doctor for the Athletics Federation of India, and instead
of being given a standard urine or blood test, the doctor said he would perform an
ultrasound. She was confused, but the doctor assured her it was routine.
In fact, the ultrasound test was prompted by Chand’s stellar performance at
the Asian Junior Athletics Championships (AJAC). In response to her surprising
successful performance, people began to question her testosterone status. Chand’s
muscles were quite pronounced in comparison to other women, and she had a stride
people believed too impressive for someone of her stature. A few days after the
ultrasound, Chand received a letter in the mail requesting she do a gender
verification test. Within days Chand was sent to a private hospital and had her blood
drawn for her natural level of testosterone to be measured. Chand also received
chromosome analysis, an MRI and another gynecological exam. The results of her
tests indicated that her “male hormone” levels were above the “typical female
range,” which meant within the male range. Chand was banned from racing because
the IAAF feared she would have a competitive advantage from the excess
testosterone.
Chand appealed her ban to the CAS, arguing the IAAF’s regulations
discriminated against female athletes with “a particular natural physical
characteristic.”85 Though the IAAF disputed Chand’s arguments, the CAS found in
favor of Chand, finding in particular that other factors contribute to elite athletic
performance, not solely testosterone. This will be further explored in a later section.
The CAS’ findings required the IOC establish policy or guidelines for intersex at
the 2016 Rio Olympics, and the IOC instead urged the IAAF to show the CAS
evidence in support of the reinstatement of the IAAF rules on hyperandrogenism.
Chand participated in the Rio Olympics, where she did not even qualify for the 100meter semifinals.
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Chand’s failure to advance to the 100-meter semifinals at the Rio Olympics
is prime evidence the IAAF’s understanding of the beneficial effects of naturally
occurring high levels of testosterone is misguided and useless. The differences in
Semenya’s performance - gold - and Chand’s performance - did not advance to the
semifinals - alone showcase how unreliable testosterone levels can indicate
performance advantages. The IAAF’s failed actions resulted in them extending an
invitation to Chand to the world championships, a seeming concession to their
failed policy and actions. In spite of evidence of the IAAF’s failed, useless
regulations, the IAAF still argues for and pushes these regulations and their
usefulness. The IAAF is still seeking a court ruling in favor of its policies and
procedures.86
The regulations will, and do, unnecessarily and negatively affect women
with intersex conditions that result in high testosterone levels instead of solely
punishing the female athletes who are actually doping with testosterone. These
IAAF regulations on testosterone and hyperandrogenism further discriminate
against women by causing women to live in fear, to live with concerns that their
male counterparts do not experience. Women have added stressors and pressures
other than making sure they prepare their bodies for elite competition; they must
worry about something entirely out of their control, something their body naturally
produces. Semenya and Chand’s experiences are prime examples of the
discrimination women track athletes experience that men do not. The male track
athletes do not have to take drugs to suppress their natural hormones, they do not
have to have surgery that is not medically required, and they do not undergo the
social backlash and exposure of their private lives. The IAAF discriminates against
women, particularly intersex and hyperandrogenic women, and this discrimination
is in direct opposition to the Olympic charter.
In opposition to the Olympic charter
The Olympic charter codifies the “fundamental principles of Olympism.”87
The charter also establishes the relationship between the international federations
associated with the Olympics and the Olympics themselves. IAAF regulations are
in opposition to Principle 6 of the Olympic charter. Principle 6 states “any form of
discrimination affecting the Olympic Movement” is prohibited.88
At the minimum, there should be a fairness applicable to all women, if not
all men, too. A woman who has been living as a woman her whole life, and who
has not doped, should be able to compete as a woman. Additionally, women should
not have to forfeit the opportunity to represent their country because of the way
their body naturally functions, especially if the options are do not compete at all or
undergo invasive, embarrassing hormone therapy and surgery.
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Lack scientific backing
The medical decisions in Olympic female athlete hyperandrogenism cases
have absolutely no scientific backing.
IAAF health and science department researchers conducted a study and
concluded that the heightened testosterone levels in elite female track athletes
provided an impactful performance boost. 1,332 female athletes, competing in
various track and field events at the 2011 and 2013 world championships, had their
blood testosterone levels measured.89 The results of the study indicated that those
participants with the highest levels of testosterone demonstrated “significant
advantages” or, in other words, ran faster than those participants with the lowest
levels of testosterone. The head researcher found this to be “new evidence [of] the
performance-enhancing effects of androgens in elite female athletes.”90 However,
this understanding of how testosterone works in athletes has been rebutted by other
reputable scientists and studies.
The assumption that the naturally occurring high levels of testosterone give
an unfair advantage in competition is woefully misguided, as evidenced by Dutee
Chand failing to make it past the first round at the 2017 World Athletic
Championships. Success can be attributed to many other factors such as genes on
the Y chromosome that control height and lean body mass.91 Body composition is
a key feature in elite sports.92 In 2014, a study measuring the profile of hormones
in a select group of elite athletes was published in Clinical Endocrinology.93 Blood
samples from 813 volunteer elite athletes from 15 different sport categories were
obtained. A subset of 693 of the 813 had their endocrine profile measured. These
samples were drawn within two hours post major national or international
competition. The study obtained hormone profiles on 454 male and 239 female
athletes. This was the first study to document hormone profiles in elite male and
female athletes. The study’s findings are significant to debunk IAAF and IOC
beliefs about the “normal” testosterone levels in a woman.
The first finding to puncture a hole in the IAAF’s ill-informed belief in
testosterone levels indicating who is “woman” enough to perform is the impact of
lean body mass (LBM) on performance. Difference in LBM sufficiently accounts
for observed differences in strength and performance. The study found that women
had an LBM of 85% that of men, a 10-kg difference in LBM in elite female athletes,
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and that LBM is the most likely explanation for differences in performance, not
testosterone.94
The elite female athletes had high levels of testosterone, the upper limit of
the normal male range, but the normal serum testosterone (LH) and folliclestimulating hormone (FSH) in those women indicates women may have had other
issues such as androgen insensitivity syndrome, polycystic ovary syndrome, or
hyperandrogenism.95 The high levels do not indicate a competitive advantage or
intentional doping.
Additionally, the study found low serum testosterone values in the elite
male athletes, another indicator that serum testosterone does not determine athletic
performance.96 These male athletes run faster than the female athletes, running
some of the fastest times in history, but they have low testosterone levels at
performance time, indicating how little role testosterone can have in performance.
Athletes had different mean testosterone levels between genders, but there existed
a complete overlap of the range of testosterone concentrations. This overlap
indicates that limiting participation of female athletes based on “normal” serum
testosterone levels is incorrect and in need of overhaul.
The study concluded there is “no clear separation between the testosterone
levels of male and female elite athletes.”97 The findings of this study totally negate
the IAAF and IOC belief that testosterone levels determine performance and
competitive advantage and restriction of women without “normal” serum
testosterone levels. Elite female athletes as a group generally have higher
testosterone levels than the average woman.98 Raised levels of testosterone in
women can be caused by other occurrences and wholly unrelated to unfair doping,
such as cysts or other ovarian syndromes.99
Anti-doping regulations are in place to punish people who are cheating, and
satisfy that purpose in instances like the Russian doping scandal. However, the
IAAF director has already admitted hyperandrogenism is not an issue of cheating
because no one is cheating.100 He acknowledged this is a biological issue. Perhaps
he should seriously consider what the biological experts know.
Violating ethical standards
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The medical practices required by the IAAF standards violate the ethical
standards of clinical practice.
A study in France that was carried out in a way that mirrored IAAF testing
was found to violate ethical standards of clinical practice.101 The Sonsken piece
found that since those practices were the same as the IAAF testing practices and
found unethical, than the IAAF practices are surely unethical. 102 The study found
devastating effects on athletes due to the trauma from the testing and having their
identity questioned.103
Other unethical practices the study explored the IAAF has also carried out.
For example, the IAAF gender requirements and testing result in unnecessary
surgeries and medical procedures, just as the France study did.104 Other non-athlete
women with similar biological characteristics do not require these same surgeries
or procedures. This raises serious ethical concerns since the testing and practices
are only needed for eligibility purposes, not health purposes. Practices in the study
and suggested by the IAAF, like the removal of gonads and clitoral mutilation for
the purposes of athletic eligibility, are unethical especially since hyperandrogenism
does not cause morbidity or indicate disease, which actually warrant the removal
of gonads and clitoral mutilation. 105 In fact, the IAAF regulations to lower
testosterone levels directly conflict with the medical approach to
hyperandrogenism.106 The IAAF offers to pay for some procedures, not all, and
does not provide for after care.107 This is sure to have a negative impact on athletes
from regions lacking the resources for necessary medical supervision and long-term
follow up.108 For the athletes who require lifelong hormone replacement, the
upkeep might be entirely too expensive. The short term and long term medical
implications of these unnecessary procedures are widespread. Such practices are
unacceptable in the medical field outside the IAAF realm.
These policies, practices and effects trickle down and extend beyond elite,
international level competitors. The IOC requires national Olympic committees
“‘actively investigate any perceived deviation in sex characteristics’ before
registering athletes.”109 India has already created a policy for discerning sex
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characteristics that applies to women athletes at every level. 110 Four young female
athletes, ages 18 to 21, have already undergone unnecessary gonadectomy
procedures to comply with IOC requirements.111 They were subject to more than
the average procedures, undergoing “karyotyping and genetic analysis, abdominalpelvic magnetic resonance imaging, and radiography to determine bone mineral
density and composition.”112 In a traditional medical scenario, doctors, at least in
the United States, would likely have their licenses revoked for such practices.
The IAAFs procedures are invasive, irreversible, and potentially
widespread.113 Due to the IOC mandate to investigate any perceived abnormal sex
characteristics in athletes, young female athletes are subject to gonadectomy
procedures and partial clitoridectomies to achieve the requisite womanhood.114
Because of the testosterone limits allowed in women athletes, 14% of women
athletes are subject to being investigated for “hyperandrogenism”, and all the
invasive, unethical procedures that come with it.115
V.

Conclusion

Going forward, it appears the IAAF and IOC have only two options: adapt
or cease to exist. People, sports fans and participants domestically and
internationally, will find a way to overhaul the IAAF and their unethical,
discriminatory practices. To avoid dying out, the IAAF first needs to make and
apply rules equally to men and women, and these rules need to completely disregard
the way someone was born. If the IAAF wants to keep these stringent rules,
punishing female athletes with naturally occurring high levels of testosterone then
the IAAF must do the same for male athletes. In the greatest interest of fairness, the
regulations regarding the eligibility of hyperandrogenic women athletes, including
the unnecessarily invasive medical intervention and “corrective” treatments, should
be rescinded immediately. At the end of the day, if a woman has lived as a woman
her whole life, the IAAF should, and frankly must, let her compete with the women.
The counter to this argument is the question of how do transgender athletes fit in,
but that is outside the scope of this paper.
In every other field, the law changes as the times change, as more people
come to recognize what is right and what is clearly so very wrong. Slavery.
Women’s suffrage. Jim Crow. Gay rights. Just as those have changed, so the IAAF
needs to change. And the IAAF needs to learn from history. Most of those historical
changes occurred much later than they could and should have. People surely
regretted being on the wrong side of history. The IAAF must do all it can to avoid
having those regrets, too.
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